Prion

Prions require only protein, and no nucleic acid, as the basis of their infectivity and pathogenicity. It is the protein alone that is the infectious agent. Defnition: "small proteinaceous infectious particles which resist inactivation by procedures that modify nucleic acids". Prion diseases are often called spongiform encephalopathies. All the diseases supposedly caused by prions affect mainly brain structures and neuronal tissues, and are untreatable and fatal.

Contents 1 Discovery 2 Origin 3 Prionic Diseases 3.1 Human TSE’s: 4 Elimination 5 Diagnosis And Treatment 6 Links 6.1 Bibliography

edit Discovery

In the 1960’s, radiation specialist Tikvah Alper, and mathematician John Stanley Griffith developed the hypothesis that the transmissible spongiform encephalopathies (TSE) could be caused by infections agents composed only by protein. It originated from the observation that the causative agent of scrapie and Creutzfeldt-Jakob disease was resistant to Ultra Violet radiation (which directly damages DNA molecules). In 1982, Stanley B. Prusiner isolated the hypothetic infectious prion, and coined the term “Prion” and “PrP” (for Protease resistant Protein, or Prion Protein). He was awarded the Nobel Prize in 1997.

edit Origin

The gene prnp codes for cellular prion protein (PrP^c), which is present in the membrane of almost every cell of the body (not present in Purkinje cells, for example). Its function is not yet clarified and continues to be studied. Probable functions include:

• Interneuronal communication;
• Maintenance of intracellular Copper (II) concentration, through its amino-terminal binding site;
• Transport or metabolism of zinc;
• Oxidative stress protection;
• Role in cellular excitation and synaptic transmission;
• Apoptosis.

The prnp gene is highly conserved, illustrating the importance of the non-pathogenic PrP protein.

A prion disease develops when the PrP^c is changed to its pathogenic isoform, PrP^sc (“sc” from “scrapies”, the most studied). The change occurs due to mutation of the gene (hereditary, sporadic), or by infection.

The diference between PrP^c and PrP^sc is found exclusively in the protein conformation: PrP^c has a 42% α-helical and 3% β sheet morphology, while in PrP^sc the proportions change to a predominance of β sheets. The amino acid sequence is exactly the same.

edit Prionic Diseases

One can develop a disease of prion origin through several ways:

• Hereditary;
• Sporadic (de novo mutation);
• Contact with infected animal products (esp. brain tissue), cannibalism;
• Infected surgical material;
• Transplant (in theory, never recorded).

It should be stressed the danger that the prion diseases pose to global populations, since prions are more resistant to destruction than any other known pathogenic agent. They are more stable and long lasting than spores and cannot be neutralized by radiation. Furthermore, there are no routine procedures for their detection.

Pathogenic prions are the causative agents of the so-called spongiform encephalopathies, named after the sponge-like appearance of the affected brain tissue. This is consequence of the amyloid accumulation of PrP^sc, which accumulates inside of lysosomes (they are resistant to protease K), eventually leading to their rupture, resulting in the cytoplasmic digestion by the lysossomal enzymes, and cell death.

Clinically speaking, prionic diseases present with extremely fast mental degeneration, like seen in eg. Alzheimer’s, but settled in 3-5 months, instead of years, as well as a rise of 14-3-3 protein level in CSF, a protein also risen in eg. acute encephalitis or brain infarction, ie. a sign of acute brain tissue destruction. Nevertheless, currently the only proof of the diagnosis is obtainable exclusively post-mortem.

edit Human TSE’s:

• Kuru;
• Creutzfeldt-Jacob disease (variant, familial, sporadic and iatrogenic);
• Gerstmann–Sträussler–Scheinker syndrome;
• Fatal Familial Insomnia.

edit Elimination

Being a protein, to inactivate a prion it is necessary to denature it. Three procedures are recommended by the World Health Organization to sterilize heat-resistant surgical instruments in this manner:

• Immerse in a pan containing 1N NaOH and heat in a gravity-displacement autoclave at 121°C for 30 minutes; clean; rinse in water; and then perform routine sterilization processes.
• Immerse in 1N NaOH or sodium hypochlorite (20,000 parts per million available chlorine) for 1 hour; transfer instruments to water; heat in a gravity-displacement autoclave at 121°C for 1 hour; clean; and then perform routine sterilization processes.
• Immerse in 1N NaOH or sodium hypochlorite (20,000 parts per million available chlorine) for 1 hour; remove and rinse in water, then transfer to an open pan and heat in a gravity-displacement (121°C) or in a porous-load (134°C) autoclave for 1 hour; clean; and then perform routine sterilization processes.

edit Diagnosis And Treatment

Using Surround Optical Fiber Immunoassay (SOFIA) and anti-PrP^sc antibodies, a team of scientists in 2010 reported being able to detect PrP^sc in concentrations of 1/10¹¹ in brain tissue.

There are studies of future therapies using anti-cytosolic PrP^sc antibodies capable of crossing the Blood-Brain Barrier. It was also discovered that lichens (symbiotic organism composed of a fungus - the mycobiont - with a photosynthetic partner - the photobiont or phycobiont -, usually either green algae or cyanobacterium) can degrade prions.

edit Links

edit Bibliography

• Encefalopatia Espongiforme Sub-aguda: Demências priônicas
• CORREIA, José Henrique R. D., CORREIA, António A. D. Initiation and replication of prion pathogenic synthesis in transmissible spongiform encephalopathy. Revista Portuguesa de *Ciências Veterinárias.
• TAYLOR, David R., HOOPER, Nigel M. The prion protein and lipid rafts.
• NORSTROM, Eric M., MASTRIANNI, James A. The Charge Structure of Helix 1 in the Prion Protein Regulates Conversion to Pathogenic PrPSc.
• BENNION, Brian J., DEMARCO, Mari L., DAGGETT, Valerie. Preventing Misfolding of the Prion Protein by Trimethylamine.
• CAMPANA, Vincenza, SARNATARO, Daniela, ZURZOLO, Chiara. N-OxideThe highways and byways of prion protein trafficking.
• Sutton JM, Dickinson J, Walker JT, Raven ND (September 2006). "Methods to minimize the risks of Creutzfeldt-Jakob disease transmission by surgical procedures: where to set the standard?". Clinical Infectious Diseases 43 (6): 757–64. doi:10.1086/507030. PMID 16912952.
• F.S. Dobson (2000) Lichens, an illustrated guide to the British and Irish species. Richmond Publishing Co. Ltd., Slough, UK
• http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0009804 - Acessed 02/02/2012
• Johnson, Christopher; James P. Bennett, Steven M. Biro, Juan Camilo Duque-Velasquez, Cynthia M. Rodriguez, Richard A. Bessen, Tonie E. Rocke (17th). "Degradation of the Disease-Associated Prion Protein by a Serine Protease from Lichens". PLoS ONE.